01/19/2022 | News release | Distributed by Public on 01/20/2022 00:21
As part of the FTC's ongoing efforts to protect you from shady sellers during the pandemic, the agency sent cease and desist demands to 25 companies that claimed their products can prevent or treat COVID-19. Treatments peddled by these companies include the use of vitamin C infusions, Ivermectin, peptide therapies, herbal remedies, teas, juices, filtered water, nasal irrigation, and seaweed extract. But there is no proof, as required by law, that any of these products can prevent or treat COVID-19 or the Delta or Omicron variants.
The companies identified today used social media to promote their unproven products. The sellers have 48 hours to notify the FTC of the specific actions they have taken to address the agency's concerns. Companies failing to make adequate corrections could be sued under the 2020 COVID-19 Consumer Protection Act. Not only does the law make it illegal to deceptively market products that claim to prevent, treat, or cure COVID-19, it also lets the FTC seek financial penalties. In all, the agency has sent similar health-related cease and desist demands to more than 400 companies and individuals.
When it comes to fighting COVID-19 and spotting unsupported treatment claims, remember:
If you suspect fraud, tell the FTC at ReportFraud.ftc.gov.
So, who are these 25 companies? Why aren't you naming them?
This blog links to the press release, which lists the companies. Click on the words in blue letters at the start of the second paragraph: companies identified today to connect to the press release.
Apparently I didn't see the list of 25 company names? It would be helpful to know that.
This blog links to the press release, which lists the companies. Click on the words in blue letters at the start of the second paragraph: companies identified today to connect to the press release.
Why can't we get the names of the companies?
This blog links to the press release, which lists the companies. Click on the words in blue letters at the start of the second paragraph: companies identified today to connect to the press release.
It is your choice whether to submit a comment. If you do, you must create a user name, or we will not post your comment. The Federal Trade Commission Act authorizes this information collection for purposes of managing online comments. Comments and user names are part of the Federal Trade Commission's (FTC) public records system, and user names also are part of the FTC's computer user records system. We may routinely use these records as described in the FTC's Privacy Act system notices. For more information on how the FTC handles information that we collect, please read our privacy policy.
This is a moderated blog; we review all comments before they are posted. We expect participants to treat each other and the bloggers with respect. We will not post comments that do not comply with our commenting policy. We may edit comments to remove links to commercial websites or personal information before posting them.
We won't post:
Comments submitted to this blog become part of the public domain. To protect your privacy and the privacy of others, please do not include personal information. Also, do not use this blog to report fraud; instead, file a complaint.